Quick Answer
Innoviva, Inc. reported Research And Development Expense of $30.60 million for the year ending 2025.
- Innoviva, Inc. showed an increase of +124.1% in Research And Development Expense from 2024 to 2025.
- This data is from Innoviva, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), Innoviva, Inc.'s Research And Development Expense has declined by 60.5%.
- Historical annual values: Fiscal year 2025: $30.60 million | Fiscal year 2024: $13.65 million | Fiscal year 2023: $33.92 million | Fiscal year 2022: $41.43 million | Fiscal year 2021: $576.0 thousand | Fiscal year 2020: $1.79 million | Fiscal year 2019: $0.00 | Fiscal year 2018: $0.00 | Fiscal year 2017: $1.36 million | Fiscal year 2016: $1.39 million | Fiscal year 2015: $2.62 million | Fiscal year 2014: $7.50 million | Fiscal year 2013: $9.04 million | Fiscal year 2012: $8.15 million | Fiscal year 2011: $103.57 million | Fiscal year 2010: $75.07 million | Fiscal year 2009: $77.52 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: